News iCAD, Inc.

Equities

ICAD

US44934S2068

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-25 pm EDT			5-day change	1st Jan Change
1.48 ^USD	-5.13%		-6.92%	-16.38%

Apr. 11	ICAD, Inc. Showcases New Profound Cloud, Enhanced Profound Detection Workstation Features at SBI Annual Symposium	CI
Apr. 09	ICAD, Inc. and Densitas, Inc. Partner to Enhance Precision Breast Health with Leading AI Solutions for Mammography Quality, Cancer Detection, and Risk Evaluation	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

ICAD Showcases New ProFound Cloud, Enhanced ProFound Detection Workstation Features and New Strategic Partnerships at SBI Annual Symposium	Apr. 11	AQ
ICAD, Inc. Showcases New Profound Cloud, Enhanced Profound Detection Workstation Features at SBI Annual Symposium	Apr. 11	CI
ICAD and Densitas Partner to Enhance Precision Breast Health with Leading AI Solutions for Mammography Quality, Cancer Detection, and Risk Evaluation	Apr. 09	AQ
ICAD, Inc. and Densitas, Inc. Partner to Enhance Precision Breast Health with Leading AI Solutions for Mammography Quality, Cancer Detection, and Risk Evaluation	Apr. 09	CI
ICAD’s ProFound AI Suite Uncovers Hidden Heart Disease Risk According to New Data Presented at American College of Cardiology Meeting	Apr. 08	AQ
ICAD Partners with RAD-AID to Advance Breast Cancer Detection Using AI in Underserved Regions and Low- and Middle-Income Countries (LMICs)	Apr. 03	AQ
ICAD Unveils ProFound Cloud, Enabling Interoperability and Access to Breast AI Solutions at Enterprise Scale	Apr. 02	AQ
ICAD, Inc. Announces Commercial Availability of ProFound Cloud	Apr. 02	CI
ICAD Releases Enhanced ProFound Detection Workstation Features to Streamline Mammogram Interpretation for Radiologists	Mar. 19	AQ
Transcript : ICAD, Inc., Q4 2023 Earnings Call, Mar 12, 2024	Mar. 12
Earnings Flash (ICAD) ICAD Posts Q4 Revenue $4.7M, vs. Street Est of $4.3M	Mar. 12	MT
ICAD, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	Mar. 12	CI
ICAD Announces Fiscal Fourth Quarter and Full-Year 2023 Financial Results	Mar. 12	AQ
ICad to Present Three Mammography Studies at Radiology Conference; Shares Rise	Feb. 28	MT
ICAD Highlights Promising Clinical Data Demonstrating Ability to Reduce Breast Interval Cancer Rates and Decrease Recall Rates at ECR 2024; Showcases Additional Platform Offerings	Feb. 28	AQ
ICAD expands Board of Directors with the appointment of Dr. Hedvig Hricak, MD, PhD, (Dr.h.cᵐ)	Feb. 27	AQ
ICAD to Report Fourth Quarter and Full Year 2023 Financial Results on March 12, 2024	Feb. 27	AQ
ICAD, Inc. Appoints Hedvig Hricak to the Board of Directors	Feb. 26	CI
ICAD to Participate in the BTIG at Snowbird: 11th Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conference	Feb. 06	AQ
ICAD Expands Board of Directors with Appointment of Michael J. Doyle, FACHE as New Board Member	Jan. 30	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News iCAD, Inc.

Equities

ICAD

US44934S2068

Summary

Filters